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Insulin is a secreted peptide that controls glucose homeostasis in mammals, and insulin biosynthe-
sis is regulated by glucose at many levels. Rodent insulin is encoded by two non-allelic genes. We
have identiﬁed a novel splice variant of the insulin2 gene in mice that constitutes about 75% of total
insulin2 mRNA. The alternate splicing does not alter the ORF but reduces the 50UTR by 12 bases. A
reporter gene containing the novel short 50UTR, is more efﬁciently expressed in cells, suggesting that
alternative splicing of insulin mRNA in mice could result in an additional level of regulation in insu-
lin biosynthesis.
 2010 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Insulin, a pancreatic peptide hormone is regulated by glucose at
various steps of insulin gene expression such as transcription,
splicing, mRNA stability and translation [1–4]. The increase in
insulin production within an hour of the glucose treatment occurs
primarily due to increase in translation with no signiﬁcant
enhancement in mRNA levels [5]. This upregulation is mediated
by binding of speciﬁc proteins in a sequence and structure speciﬁc
manner to the un-translated regions (UTR) of insulin mRNA [6,7].
Thus, any alteration to the 50UTR has the potential for differential
regulation of insulin gene expression.
Mouse insulin is encoded by two non-allelic genes [8]. The insu-
lin2 gene has two introns while the insulin1 gene contains only
one intron and is believed to have evolved by retrotransposon
mediated gene duplication with loss of intron2 [9]. Both the in-
trons of insulin2 are ﬂanked by characteristic GU-AG sequence. In-
tron1 is spliced inefﬁciently as compared to the intron2, as a result
about 2–10% of the cytoplasmic insulin2 mRNA contain intron1 [3].
This intron1 containing RNA has increased translation efﬁciency
and its level is increased in diabetic/insulin resistant mouse mod-
els [10]. We hypothesized that due to the inefﬁcient splicing, in-
tron1 can be alternatively spliced by using one or more cryptic
splice-sites that are present in the vicinity. Analysis of the mouse
insulin2 gene sequences identiﬁed the presence of a putative alter-
native 30-splice-site for intron1. This new cryptic splice-site is used
predominantly and the alternatively spliced mRNA is expressed inchemical Societies. Published by E
yahoo.com (V. Seshadri).multiple mouse species as well as in insulin producing cell lines.
We also show that reporter mRNA containing the new splice vari-
ant at the 50UTR is expressed more efﬁciently when compared to
the splice variant of the insulin2 mRNA.
2. Materials and methods
2.1. Mouse islet isolation
All animal work was performed as per the IEAUC guidelines and
approval. Six to eight weeks old BALB/c or C57BL6 mice were used.
Pancreatic islets were prepared as described previously [11] and
puriﬁed on Ficoll gradient.
2.2. RNA extraction, RT-PCR, and structure prediction
Total RNA was prepared using TRIzol reagent and cDNA was
synthesised using ImProm-II Reverse Transcriptase Kit (Promega).
For sequencing of splice variants, Insulin2 gene was PCR ampliﬁed
with gene speciﬁc primers 1 and 4 (Table S1). Secondary structure
of the RNA was predicted using the m-fold algorithm [12].
2.3. Cell culture and transfection
2  105 cells (bTC6 and HEK293), maintained in DMEM, 10%
FCS, 100 U/ml penicillin and streptomycin, were transfected with
50UTR containing ﬁreﬂy luciferase (100 ng) and Renilla luciferase
(1 ng) DNA using Lipofectamin 2000 (Invitrogen). Cells were har-
vested after 16 h and the Fireﬂy and Renilla luciferase activities
were measured using the DLR Kit (Promega).lsevier B.V. All rights reserved.
Table 1
Comparison of the splice-sites of intron1 of insulin.
Genes 50-Splice-site
of intron1
30-Splice-site
of intron1
Intron1
(bases)
Intron2
(bases)
Consensus AG/GURAG YAG/GU
Human insulin AG/GUCUG CAG/AU 179 786
Rat Ins 1 AG/GUAUG CAG/GU 119 0
Rat Ins 2 AG/GUAUG CAG/GU 119 499
Mouse-Ins1 AG/GUAUG CAG/GU 118 0
Mouse-Ins2 AG/GUACU CAG/CC 102 486
Mouse-Ins2-S AG/GUACU CAG/GU 114 486
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The Polysome fractionation was done as described previously
[13]. Brieﬂy, 5  106 bTC6 cells were washed and homogenized
in 1.5 ml of the homogenization buffer (10 mM Tris-pH 8.0,
25 mM KCl, 10 mM MgCl2, 250 mM sucrose, 2 mM DTT, 0.1 lg/
ml cycloheximide, protease inhibitor, 100 U/ml RNasin). After an
initial 10 s centrifugation at 12 000g to remove the nuclei, the
supernatant was centrifuged for 12 min at 130 000g. RNA was
isolated from the pellet (polysome) and the supernatant (non-
polysome) fraction.
2.5. Plasmid constructs
Double stranded oligonucleotides corresponding to mIns2,
mIns2-S 50UTR and mIns2 30UTR were cloned in pSP64-luc-
Cp30UTR-polyA plasmid (gift from Dr. Paul Fox, LRI, Clevelandm
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Fig. 1. Mouse Insulin2 splice variant in pancreatic islets. (A) Schematic representation of
introns, (dotted lines). The translation start site is in exon 2 and the stop codon in exon
splice-site junction. The position of the primers used for RT-PCR is indicated with numb
insulin2 with the primers 2 and 3. PCR reactions were resolved on agarose gel and sample
recognition sequence (underlined in A), hence only the mIns2 isoform will be digestedClinic Foundation). Insulin 50-UTR-Luc-30UTR fragments from the
pSP64 vector were sub cloned in pcDNA3 vector for expression in
eukaryotic cell lines.
2.6. RNA-EMSA
The cytoplasmic extracts were prepared as described previously
[7]. RNA-EMSA was done with 2 lg of extracts. For competition
experiments, 200 ng (70-fold molar excess) of unlabeled RNA
was added to the reaction mix and incubated at room temperature
for 5 min, prior to the addition of extract.
3. Results
3.1. A novel insulin splice variant is expressed in mouse pancreatic
islets
Introns of the mouse insulin2 RNA splice out with different efﬁ-
ciency. The 50 (AG/GU) as well as the 30-splice-site (AG/CC) se-
quence of intron1 are not optimal for mammalian splicing (Table.
1). Sequence analysis of insulin2, revealed the presence of a poten-
tial 30-splice-site, 12 bp downstream to the known splice-site
(Fig. 1A). RT-PCR ampliﬁcation of the insulin mRNA from islets of
BALB/c mice using primers in the exon1 and exon2 resulted in
two speciﬁc products corresponding to the expected size of the
two alternately spliced mRNA (Fig. 1B). Sequence analysis as well
as restriction digestion with speciﬁc restriction enzyme (BstNI)
conﬁrmed that the shorter product (mIns2-S) corresponds to the
splice variant that uses the cryptic splice-site and the longerm
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the mouse proinsulin2 gene. Insulin2 gene consists of three exons (boxes), and two
3. The 50UTR includes exon 1 and part of exon 2; the arrow head shows the new 30-
ers. (B) Mouse islet cDNA was used for PCR of insulin1 with primers 5 and 6, and
s are as indicated. (C) Deletion of 12 bases in the mIns2-S isoforms remove the BstNI
and 78 bp and 51 bp fragments will be released.
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Fig. 2. Quantiﬁcation of Ins2 isoforms. (A) RT-PCR of both the isoforms was
performed in the same reaction using the primer 2 and primer 3 for two different
cDNA preparations, with the amount of cDNA used indicated above the lane. The
top and bottom bands correspond to mIns and mIns2-S isoforms respectively. (B)
Two bands in the (A) were quantitated and are presented as percentage of total
mouse insulin2 mRNA in pancreatic islets. The graph represents the average of
results from three independent experiments.
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Fig. 3. Translation efﬁciency of the splice isoforms. mIns2 or mIns2-S 50UTR-luc
pCDNA3 were transfected along with Renilla-luciferase plasmid in (A) HEK293 or
(B) bTC6 cells. Translation of luciferase was normalized with renilla levels and
expressed as fraction of translation of the Ins2 50UTR containing plasmid. The lower
panel indicates the amount of luciferase RNA at the end of transfection as detected
by RT-PCR. (C) RNA isolated from the polysome fractions was quantitated for the
two splice isoforms of the insulin2 RNA. The results are expressed as percentage
change from the expected percentage in the total RNA pool (75% for mIns2-S and
25% for mIns2). All the experiments were done in triplicates and the graphs
represent the average of three independent experiments and the error bar indicates
the S.E.M.
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(Fig. 1C). Islets from C57BL6 mice produced similar results
(Fig. S1A).
Insulin2 genomic region was ampliﬁed from the pancreatic is-
lets of BALB/c mouse as well as in bTC6 cells and sequenced. Se-
quence analysis revealed that there was no alteration in the
splice-site consensus sequence at the genomic level. Thus, the
expression of mIns2-S is not due to mutations in the genomic
DNA, but rather due to alternate splicing. Further, this novel short
isoform was also expressed in bTC6 and MIN6 cell lines (mouse
insulinoma cell lines), (Fig. S1B and C).
3.2. mIns2-S splice variant is the major product in pancreatic islets
mIns2-S splice variant uses the 30-splice-site that is similar to
the consensus mammalian sequence and should be spliced very
efﬁciently [14]. Expression of the two splice isoforms was mea-
sured in pancreatic islets using quantitative PCR. Primers that am-
plify both the splice isoforms were used to perform RT-PCR with
varying amounts of the cDNA. mIns2-S splice variant was found
to be the predominant form (75% of total mouse insulin2 mRNA)
in pancreatic islets (Fig. 2). These results were further conﬁrmed by
RT-PCR analysis using isoform speciﬁc primers (Fig. S2).
3.3. Translation efﬁciency of the mIns2-S splice variant is increased
We have shown previously that translation of insulin is regu-
lated by the 50UTR [7]. To analyze the translation efﬁciency of
the mIns2-S and mIns2, HEK and bTC6 cells were transfected with
plasmid encoding the ﬁreﬂy luciferase with mIns2-S or mIns2
50UTR. The relative luciferase activity revealed that the expression
levels of the mIns2-S isoform is 300% greater than that of the
mIns2 isoform without signiﬁcant change in the RNA levels
(Fig. 3). These results suggest that the basal translation rate of
the mIns2-S isoform is higher compared to the mIns2 isoform.
The glucose stimulated translation of these two splice isoforms is
not altered in insulin producing bTC6 cells (Fig. S3).
Actively translating RNA is associated with polysomes and the
amount of polysome-associated RNA can be correlated with trans-
lation efﬁciency. Insulin2 RNA splice variants associated with dif-ferent fractions were measured by quantitative RT-PCR.
Association of mIns2-S isoform with polysomes was 5% higher
than what was expected from their abundance in the total RNA,
while the mIns2 association with polysome is 7% lower
(Fig. 3C). These results are consistent with the in vivo translation
assay.
Translation of speciﬁc mRNAs is often controlled by its cis-act-
ing elements with speciﬁc secondary structure in the 50UTR [15].
The loss of 12 bases at the 50UTR results in dramatic alteration to
the predicted secondary structure of the 50UTR (Fig. 4). This altered
secondary structure could probably result in loss/gain of recogni-
tion by speciﬁc cellular factors that may contribute to the differen-
tial translation of the splice isoforms.
3.4. Altered binding of cellular factors to mIns2-S splice variant
Binding of speciﬁc factors to the 50UTR of insulin2 RNA was ana-
lyzed using RNA-EMSA. A speciﬁc RNA-protein complex was de-
tected using either of the splice variant UTR as probes (Fig. 5). In
competitive EMSA, mIns2 was able to compete very effectively as
compared to the mIns2-S, suggesting a higher binding afﬁnity/sta-
bility of the mIns2 complex.
4. Discussion
Recent studies have suggested that about half of the mamma-
lian genes undergo alternative splicing [16]. Many such events re-
sult in changes in the 50UTR and can affect the translation
efﬁciency, as in case of insulin. In this study, we show that mouse
Fig. 4. Secondary structure of mIns2 and mIns2-S 50UTRs. Bent arrows indicate the start of the open reading frame. The shaded area in the left panel corresponds to the 12
nucleotide sequence that is spliced out in mIns2-S. The splice junction is indicated by a straight arrow.
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Fig. 5. RNA-EMSA using the radio labeled mIns2 and mIns2-S RNA as probes and
extracts from HEK293 cells. The speciﬁc cold competitor RNA (CC) used is indicated.
Arrow indicates the speciﬁc RNA-protein complex.
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transcripts containing distinct 50UTRs (mIns2 and mIns2-S) with-
out altering the coding sequence. Intron1 of insulin2 has mis-
matches compared to the consensus mammalian splice-site (the
50 donor sequence matches 5/7 and the 30 acceptor sequence
matches 3/5) [14]. The novel mouse insulin2 splice variant
(mIns2-S: GQ915612) that uses a 30 acceptor sequence down-
stream to that of the mouse insulin2 mRNA (mIns2:
NM_008387), matches perfectly to the consensus sequence. Fur-
ther both mIns2-S and mIns2 mRNAs coexist in the adult BALB/c
and C57BL6 pancreatic islets and the mIns2-S isoform contributes
75% of the total insulin2 RNA. The 50 and 30-splice-sites of intron1
of mouse insulin1 and, in insulin genes of rat and human are opti-
mal for efﬁcient splicing (Table 1), hence we did not detect this
splice variant in these species.The usage of the distal 30-splice-site increases the intron length,
thereby increasing the splicing efﬁciency [17]. In pancreatic b cells
the insulin mRNA is 10% of the total mRNA and to maintain such
high level of insulin mRNA, the transcription/processing rate has to
be very high which allows the usage of the strong distal 30-splice-
site preferentially [18]. A human splice variant uses a cryptic
splice-site within intron1 that retains 26 bases of intron1 in the
processed mRNA. The altered 50UTR containing mRNA shows in-
creased translation activity [19]. Similarly, intron1 of Rat insulin1
increases the expression of reporter gene, by regulating the tran-
scription and processing [20].
50UTR sequences have been reported to regulate translation by
secondary structure formation and uORFs [21]. Alternative tran-
scription start site of embryonic insulin mRNA results in a longer
50UTR containing upstream AUGs, resulting in very low level trans-
lation of the proinsulin [22]. Rat insulin 50UTR is 70 nt and forms
a speciﬁc secondary structure with regulatory elements that con-
trol its translation [23]. Results from our transfection experiments
show that the Ins2-S splice variant is 3-fold more translatable as
compared to the Ins2 isoform (Fig. 3). Absence of upstream AUGs in
either of the splice variant indicate that secondary structure may
be responsible for the altered translation efﬁciency. Binding of spe-
ciﬁc proteins to the 50UTR correlates with decreased translation,
suggesting that the binding factor is probably an inhibitor of the
translation. The presence of the novel splice variant in different
strains of mice as well as in insulinoma cell line suggests that
the use of the stronger splice-site is not strain speciﬁc. Thus, the
splicing of intron1 could be an additional regulated event in mice
affecting the insulin biosynthesis. Although we did not detect
any alteration in the expression of these splice isoforms in mice is-
lets with age (from 2 months to 2 years) or with the short term
exposure to glucose in cell lines, the possibility of tissue speciﬁc
expression in non-pancreatic cells and regulated expression in dia-
betic/insulin resistant mice or after long term glucose exposure
cannot be excluded.
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